Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice

J Immunol. 1999 Jun 15;162(12):6955-8.

Abstract

Protection against intracellular bacteria by T cells is regulated by Ag-presenting molecules, which comprise classical MHC class I molecules, MHC class II molecules, and nonclassical MHC class Ib molecules. The role of CD1 molecules, which are structurally similar to classical MHC class I gene products, but less polymorphic, is not understood so far. We show that CD1 surface expression increased on APC in Listeria-infected mice. The in vivo treatment with anti-CD1 mAb reduced TGF-beta 2 levels and concomitantly increased secretion of the proinflammatory cytokine TNF, the Th1 cell promoting cytokine IL-12, and the Th1 cell cytokine IFN-gamma at the onset of listerial infection. These findings point to a regulatory role of CD1-reactive cells in the immune response against listeriosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD1 / biosynthesis
  • Antigens, CD1 / immunology*
  • Cytokines / antagonists & inhibitors*
  • Cytokines / biosynthesis
  • Cytokines / metabolism
  • Female
  • Listeriosis / immunology*
  • Listeriosis / metabolism
  • Listeriosis / therapy
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Th1 Cells / metabolism*
  • Transforming Growth Factor beta / antagonists & inhibitors*
  • Transforming Growth Factor beta / biosynthesis

Substances

  • Antibodies, Monoclonal
  • Antigens, CD1
  • Cytokines
  • Transforming Growth Factor beta